Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TAF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HSPB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLP2R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NAA16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIRPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNA1H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAATS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC26A4-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
UBQLN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LONRF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APLF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NKX3-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF430 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on